Risuteganib for the treatment of DME


Peter Kaiser, MD, shares how risuteganib (Luminate, Allegro) can help with the treatment of DME when anti-VEGF treatment isn't a viable option. He presented his research  in Vancouver, British Columbia, during the 2018 annual meeting of the American Society of Retina Specialists.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.